AFC
IDXX icon

Ares Financial Consulting’s Idexx Laboratories IDXX Stock Holding History

Ares Financial Consulting’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.79K Hold
11
– – ﹤0.01% 682
2026
Q1 		$6.21K Hold
11
– – ﹤0.01% 646
2025
Q4 		$7.44K Buy
+11
New +$7.49K 0.01% 404

Other funds holding IDXX

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.86B AUM 22.16% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Ares Financial Consulting's IDXX Position: Q2 2026 in Review

Ares Financial Consulting held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 11 shares worth $5.79K. The position accounts for ﹤0.01% of the portfolio, ranked #682.

Ares Financial Consulting first reported a position in IDXX in Q4 2025 and has held it in 3 quarters since. The position peaked at $7.44K in Q4 2025. 659 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Ares Financial Consulting held 11 shares of Idexx Laboratories worth $5.79K as of Q2 2026.
  • Ares Financial Consulting left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of Ares Financial Consulting's portfolio in Q2 2026, its #682 holding.
  • Ares Financial Consulting first reported a position in Idexx Laboratories in Q4 2025 and has held it in 3 quarters since.
  • Ares Financial Consulting's Idexx Laboratories position peaked at $7.44K in Q4 2025.
  • 659 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.